Robotic-assisted system for treatment of enlarged prostate is now available at HCA Houston Healthcare Northwest

Houston, TX —  HCA Houston Healthcare Northwest announced that it has begun offering Aquablation therapy, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

BPH is an unfortunate reality of aging for millions of men and impacts urinary function, making it difficult to urinate and fully empty the bladder. Without timely treatment, BPH can lead to severe health issues such as permanent bladder or kidney damage, bladder stones and incontinence. Statistics show that approximately 50% of men aged 51-60 have BPH, which increases to 70% among men 60-69 and approximately 80% for men over 70 years of age.

The procedure integrates ultrasound imaging and digital cystoscopy to provide the surgeon with a multi-dimensional, detailed view of the entire prostate, enabling personalized treatment planning tailored to each patient’s unique anatomy. Utilizing a heat-free waterjet, the robotically assisted system executes the surgeon’s treatment plan to remove obstructive tissue while protecting critical anatomy. This enables efficient and predictable water jet resection, standardizing the operative experience across a wide range of prostate sizes and shapes. It is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes.

“BPH is a widespread condition that severely compromises quality of life for countless men over age 50. With this procedure, men can reclaim their lifestyles and find relief from symptoms while preserving sexual function and continence – outcomes that have proven elusive with many traditional treatment modalities,” said Arabinda Pani, chief medical officer.